NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 194 filers reported holding NEVRO CORP in Q4 2017. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $4,211,000 | -87.6% | 67,364 | -84.1% | 0.03% | -87.5% |
| Q2 2018 | $33,890,000 | -53.0% | 424,427 | -49.0% | 0.24% | -54.3% |
| Q1 2018 | $72,091,000 | +17.7% | 831,786 | -6.3% | 0.52% | +17.2% |
| Q4 2017 | $61,266,000 | -11.5% | 887,402 | +16.5% | 0.45% | -10.2% |
| Q3 2017 | $69,230,000 | +629.5% | 761,770 | +497.4% | 0.50% | +623.2% |
| Q2 2017 | $9,490,000 | – | 127,509 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Engaged Capital LLC | 1,885,956 | $15,879,750 | 2.72% |
| Kent Lake Capital LLC | 639,775 | $5,386,906 | 2.43% |
| Wellington Wealth Strategies, LLC. | 71 | $538,662 | 2.26% |
| Palo Alto Investors LP | 750,371 | $6,318,124 | 0.73% |
| BRAIDWELL LP | 1,698,768 | $14,303,627 | 0.45% |
| ArrowMark Colorado Holdings LLC | 4,289,108 | $36,114,289 | 0.43% |
| ARMISTICE CAPITAL, LLC | 3,672,000 | $30,918,240 | 0.39% |
| Rock Springs Capital Management LP | 1,381,500 | $11,632,230 | 0.35% |
| Eversept Partners, LP | 499,395 | $4,204,906 | 0.29% |
| Olympiad Research LP | 25,046 | $210,887 | 0.16% |